ABIVAX Societe Anonyme's stock dropped over 40% on June 2, 2026, following reports of rare malignancy cases in its Phase 3 ulcerative colitis trial for obefazimod. The sharp decline erased gains made since mid-2025 and led to a downgrade by Jefferies, which cut its price target by nearly 44%. Trading volume surged, and short interest rose to about 12% of the float. Levi & Korsinsky has launched an investigation into potential federal securities law violations related to the incident, offering support to affected shareholders.
The S&P 500's nine-week rally abruptly ended with a sharp selloff following a better-than-expected employment report. This triggered a shift in investor sentiment from high-risk growth stocks to safer value, defensive, and energy sectors. Five of twe...
United Parcel Service (UPS) is rated a buy as its shares are undervalued by about 10%, supported by a strong 6.0% dividend yield. The company reported better-than-expected earnings and revenue in Q1, reaffirmed its full-year 2026 guidance, and antici...
LAB token led crypto gainers with a 56.47% jump to $14.01, driven by the project's expanding ecosystem and a recent partnership with a major tech firm, boosting investor confidence. Other notable gainers include Audiera (BEAT), Siren (SIREN), Binance...
Hunter Biden expressed support for Bitcoin and blockchain technology, calling them the "inevitable future," despite the traditional Democratic Party's tough stance on crypto. His view contrasts with the Biden administration's SEC crackdown on crypto ...
Bouygues Telecom, Free-iliad Group, and Orange have signed a Memorandum of Understanding to acquire SFR from Altice France for a total enterprise value of €20.35 billion. The deal aims to create long-term value by strengthening France's digital infra...
